133 related articles for article (PubMed ID: 36305959)
1. Geographic disparities in access to immunotherapy clinical trials for metastatic melanoma.
Mulligan KM; Zheng DX; Xu JR; Cullison CR; Cwalina TB; Beveridge MG; Scott JF
Arch Dermatol Res; 2023 May; 315(4):1033-1036. PubMed ID: 36305959
[TBL] [Abstract][Full Text] [Related]
2. Geographic Access Disparities to Clinical Trials in Diabetic Eye Disease in the United States.
Soares RR; Parikh D; Shields CN; Peck T; Gopal A; Sharpe J; Yonekawa Y
Ophthalmol Retina; 2021 Sep; 5(9):879-887. PubMed ID: 33340769
[TBL] [Abstract][Full Text] [Related]
3. Rural-Urban Disparities in Access to Medicaid-Contracted Pharmacies in Washington State, 2017.
Graves JM; Abshire DA; Undeberg M; Forman L; Amiri S
Prev Chronic Dis; 2020 Aug; 17():E92. PubMed ID: 32816659
[TBL] [Abstract][Full Text] [Related]
4. Disparities in geographic access to pediatric subspecialty care.
Mayer ML
Matern Child Health J; 2008 Sep; 12(5):624-32. PubMed ID: 17879148
[TBL] [Abstract][Full Text] [Related]
5. Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US.
Moyers JT; Patel A; Shih W; Nagaraj G
JAMA Netw Open; 2020 Sep; 3(9):e2015656. PubMed ID: 32876684
[TBL] [Abstract][Full Text] [Related]
6. Geographic proximity to cardiovascular clinical trial sites: A National analysis in the United States.
Salerno PRVO; Bourges-Sevenier B; Chen Z; Pereira GTR; Deo S; Nasir K; Rajagopalan S; Al-Kindi S
Curr Probl Cardiol; 2024 Aug; 49(8):102683. PubMed ID: 38795807
[TBL] [Abstract][Full Text] [Related]
7. Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas.
Fanaroff AC; Yang L; Nathan AS; Khatana SAM; Julien H; Wang TY; Armstrong EJ; Treat-Jacobson D; Glaser JD; Wang G; Damrauer SM; Giri J; Groeneveld PW
J Am Heart Assoc; 2021 Sep; 10(17):e021456. PubMed ID: 34431320
[TBL] [Abstract][Full Text] [Related]
8. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract][Full Text] [Related]
9. Mapping Food Insecurity-Related 2-1-1 Calls in a 10-County Area of Central Texas by Zip Code: Exploring the Role of Geographic Food Access, Urbanicity and Demographic Indicators.
Janda KM; Salvo Dominguez D; Ranjit N; Hoelscher DM; Price A; van den Berg A
J Community Health; 2021 Feb; 46(1):86-97. PubMed ID: 32447543
[TBL] [Abstract][Full Text] [Related]
10. Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.
Unger JM; Moseley A; Symington B; Chavez-MacGregor M; Ramsey SD; Hershman DL
JAMA Netw Open; 2018 Aug; 1(4):e181235. PubMed ID: 30646114
[TBL] [Abstract][Full Text] [Related]
11. Geographic access to cancer care in the U.S.
Onega T; Duell EJ; Shi X; Wang D; Demidenko E; Goodman D
Cancer; 2008 Feb; 112(4):909-18. PubMed ID: 18189295
[TBL] [Abstract][Full Text] [Related]
12. Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
Hung P; Deng S; Zahnd WE; Adams SA; Olatosi B; Crouch EL; Eberth JM
Cancer; 2020 Mar; 126(5):1068-1076. PubMed ID: 31702829
[TBL] [Abstract][Full Text] [Related]
13. Geographic Access Disparities of Clinical Trials in Neovascular Age-Related Macular Degeneration in the United States.
Soares RR; Gopal AD; Parikh D; Shields CN; Patel S; Hinkle J; Sharpe J; Ho AC; Regillo CD; Haller J; Yonekawa Y
Am J Ophthalmol; 2021 Sep; 229():160-168. PubMed ID: 33848533
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Coronary Intervention in the United States: Risk Factors for Untimely Access.
Hsia RY; Shen YC
Health Serv Res; 2016 Apr; 51(2):592-609. PubMed ID: 26174998
[TBL] [Abstract][Full Text] [Related]
15. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI
PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864
[TBL] [Abstract][Full Text] [Related]
16. Possible geographical barriers to trauma center access for vulnerable patients in the United States: an analysis of urban and rural communities.
Hsia R; Shen YC
Arch Surg; 2011 Jan; 146(1):46-52. PubMed ID: 21242445
[TBL] [Abstract][Full Text] [Related]
17. Differential patient travel distance and time to psoriasis clinical trial sites.
Masison J; Beltrami EJ; Feng H
Arch Dermatol Res; 2023 Oct; 315(8):2359-2363. PubMed ID: 37166524
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of clinical trials that require participants to be fluent in English.
Egleston BL; Pedraza O; Wong YN; Dunbrack RL; Griffin CL; Ross EA; Beck JR
Clin Trials; 2015 Dec; 12(6):618-26. PubMed ID: 26152834
[TBL] [Abstract][Full Text] [Related]
19. Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States.
Haque W; Verma V; Butler EB; Teh BS
J Immunother; 2019; 42(6):228-235. PubMed ID: 30985445
[TBL] [Abstract][Full Text] [Related]
20. The relationship between structural racism and COVID-19 related health disparities across 10 metropolitan cities in the United States.
Ramprasad A; Qureshi F; Lee BR; Jones BL
J Natl Med Assoc; 2022 Jun; 114(3):265-273. PubMed ID: 35221074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
